Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -121,692 | -106,289 | -127,790 | 16,453 | -37,501 |
| Depreciation Amortization | 1,293 | 1,239 | 1,920 | 741 | 589 |
| Accounts receivable | -2,932 | -1,119 | -1,088 | -12 | 46,634 |
| Accounts payable and accrued liabilities | 4,396 | -1,490 | 1,457 | 1,698 | 755 |
| Other Working Capital | -3,888 | -22,936 | 487 | 12,126 | 37,246 |
| Other Operating Activity | 31,916 | 29,380 | 23,255 | 5,976 | -42,840 |
| Operating Cash Flow | $-90,907 | $-101,215 | $-101,759 | $36,982 | $4,883 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,619 | -875 | -2,877 | -1,563 | -561 |
| Purchase Of Investment | -277,883 | -240,224 | -240,413 | -145,158 | -115,566 |
| Sale Of Investment | 205,795 | 246,232 | 177,462 | 94,645 | 132,190 |
| Investing Cash Flow | $-74,707 | $5,133 | $-65,828 | $-52,076 | $16,063 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 135,570 | 9,898 | 1,261 | 14,996 | 14,890 |
| Common Stock Issued | 36,214 | N/A | 119,784 | N/A | 8,673 |
| Other Financing Activity | -11,993 | 3,234 | 104,874 | 1,896 | 352 |
| Financing Cash Flow | $159,791 | $13,132 | $225,919 | $16,892 | $23,915 |
| Beginning Cash Position | 42,256 | 125,206 | 66,874 | 65,076 | 20,215 |
| End Cash Position | 36,433 | 42,256 | 125,206 | 66,874 | 65,076 |
| Net Cash Flow | $-5,823 | $-82,950 | $58,332 | $1,798 | $44,861 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,907 | -101,215 | -101,759 | 36,982 | 4,883 |
| Capital Expenditure | -2,619 | -889 | -2,877 | -1,596 | -562 |
| Free Cash Flow | -93,526 | -102,104 | -104,636 | 35,386 | 4,321 |